Now trading at a price of $35.13, Envista has moved 3.8% so far today on a volume of 695,725, compared to its average of 1,717,919. In contrast, the S&P 500 index moved 0.6%.
Envista shares moved -25.3% over the last 52 weeks, with a high of $52.03 and a low of $31.67. During this time, the stock lagged the S&P 500 index by -8.3%. As of January 2022, the company's 50-day average price is $34.3536. Envista Holdings Corporation, together with its subsidiaries, engages in the development, sale, and marketing of dental products in the United States, China, and internationally. The mid-cap Healthcare company has 11,200 full time employees and is based in Brea, CA. Envista has not offered any dividends in the last year.
Snapshot of the Company's Thin Margins and Strong Cash Flows:
|Gross Margins Growth||n/a||-7.64%||12.01%|
|Operating Margins Growth||n/a||-85.15%||713.33%|
|Earnings Per Share||$1.6||$0.2||$1.92|
|Free Cash Flow (MM)||$320||$236||$307|
|Capital Expenditures (MM)||-$78||-$48||-$55|
|Net Debt / EBITDA||2.55||4.8||0.58|
Envista Is Reasonably Valued:
Compared to the Healthcare sector's average of 13.21, Envista has a trailing twelve month P/E ratio of 31.4 and, according to its EPS guidance of 2, an expected P/E ratio of 17.6. Envista's PEG ratio is 0.12 based on its 258.67% average growth rate of historical and projected earnings per share. This suggests that company's shares are undervalued.
Envista is undervalued in terms of its assets because its P/B ratio is 1.4 compared to its sector average of 4.07. The company's shares are currently trading 35.0% above their fair value as expressed by Benjamin Graham's formula:
√(22.5 * 3-year average EPS * book value per share) = √(22.5 * 1.24 * 24.282) = $26.03
Envista Is the Subject of Mixed Market Indicators:
9 analysts are following Envista and have set target prices ranging from $38 to $48 per share. On average, they have given the company a rating of buy. At the current price of $35.13, NVST is trading -18.72% away from its average analyst target price of $43.22 per share, implying an analyst consensus of some upside potential for the stock.
The company has an above average percentage of its shares sold short since 9.9% of the company's shares are tied to short positions. Institutions own 115.2% of Envista's shares, while the insider ownership rate stands at 0.21%. The biggest shareholder is Blackrock Inc. with a 11% stake in the company worth approximately $625,651,618.